Summary of Purpose
This study will characterize the gene response of the body's immune and inflammatory cells to stroke. There is a wide variation in stroke risk, stroke outcome, and response to clot-busting therapy for stroke. This variation may be due to differences in people's response to injury or infection, or to differences in genetic make-up between individuals. Genes store the biological information that determines the...Read More →
The following dates are available for this trial. Trial information last updated on 30 June 2017.
|3 Jun 2002||26 Jul 2006||Unavailable||15 Dec 2008||15 Dec 2008||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Patient Recruitment and Public Liaison Office Phone: (800) 411-1222 Email: firstname.lastname@example.org@mail.cc.nih.gov